Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression☆

David E. Kemp,Stephen J. Ganocy,Martin Brecher,Berit X. Carlson,Suzanne Edwards,James M. Eudicone,Gary Evoniuk,Wim T. Jansen,Andrew C. Leon,Margaret Minkwitz,Andrei Pikalov,H.H. Stassen,Armin Szegedi,Mauricio Tohen,Arjen van Willigenburg,Joseph R. Calabrese

Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression☆

2011

David E. Kemp
Stephen J. Ganocy
Martin Brecher
Berit X. Carlson
Suzanne Edwards
James M. Eudicone
Gary Evoniuk
Wim T. Jansen
Andrew C. Leon
Margaret Minkwitz
Andrei Pikalov
H.H. Stassen
Armin Szegedi
Mauricio Tohen
Arjen van Willigenburg
Joseph R. Calabrese

Objective To evaluate the clinical value of early partial symptomatic improvement in predicting the probability of response during the short-term treatment of bipolar depression.

Keywords:

Quetiapine
Bipolar disorder
Predictive value of tests
Clinical psychology
Lamotrigine
Fluoxetine
Psychiatry
Aripiprazole
Psychology
Onset of action
Antimanic Agents
clinical value

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations